Ezakard
Ezacard
Composition:
Each enteric-coated tablet contains:
Acetylsalicylic Acid 75mg
Properties:
Ezakard is a salicylate NSAID that has a bloodthinning effect.
Indications:
ischemic stroke, acute myocardial infarction, prevention of recurrent myocardial infarction, unstable angina pectoris and chronic stable angina pectoris. Reducing the risk of death in patients with ischemic stroke; with chronic stable angina pectoris. The following procedures include coronary artery bypass grafting, percutaneous transluminal coronar angioplasty, and carotid endarterectomy.
Mode of application:
inside, the tablet should be swallowed whole. Secondary prevention of thrombotic cerebrovascular or cardiovascular diseases: 75-300 mg per day. For angina pectoris: 75150 mg per day.
children under 12 years old; hypersensitivity to NSAlDs; peptic ulcer; pregnancy and breastfeeding; hemophilia and other blood clotting disorders.
Precautions:
Aspirin can prolong labor and make premature bleeding when used during the last trimester of pregnancy. Use with caution in patients with diseases of the cardiovascular system, gastrointestinal diseases (especially elderly patients), in cases of asthma, strictly under medical supervision. Do not drink alcohol during treatment.
Side effects:
the tablets do not irritate the stomach. May occur: bronchospasm, gastrointestinal hemorrhage (sometimes extensive) and other hemorrhages.
Storage method:
Store at a temperature not exceeding 30C, out of reach of children.
Packaging:
the box contains 3 blisters of 10 tablets each.